Variant NM_000492.4:c.2051_2052delinsG
Name | NM_000492.4:c.2051_2052delinsG |
Protein name | NP_000483.3:p.(Lys684Serfs*38) |
Genomic name (hg19) | chr7:g.117232272_117232273delinsG UCSC |
#Exon/intron | exon 14 |
Legacy Name | 2183AA>G |
Class | disease-causing |
Subclass | CF-causing |
WT sequence | CCTGTCTCCTGGACAGAAACAAAAA AA CAATCTTTTAAACAGACTGGAGAGT |
Mutant sequence | CCTGTCTCCTGGACAGAAACAAAAA G- CAATCTTTTAAACAGACTGGAGAGT |
dbSNP rs121908799 |
Not found |
No patient found in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 54 |
---|---|
Asymptomatic compound heterozygote | 1 |
CF | 38 |
CFTR-RD | 12
|
Pending | 1 |
Pending (NBS) | 2 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
Other | 6178 | heterozygote | |
Other | 3167 | heterozygote | CFTR-RD-causing - Trans |
Other | 4711 | heterozygote | CFTR-RD-causing- Undef |
Other | 1073 | heterozygote | varying clinical consequence- Undef |
CF | 4471 | heterozygote | CF-causing - Trans |
CF | 3097 | heterozygote | varying clinical consequence- Undef |
CF | 2955 | heterozygote | CF-causing - Trans |
CF | 2546 | heterozygote | VUS3- Undef |
CF | 2508 | heterozygote | CF-causing- Undef |
CF | 2467 | heterozygote | CF-causing- Undef |
CF | 2374 | heterozygote | varying clinical consequence- Undef |
CF | 2056 | heterozygote | CF-causing- Undef |
CF | 2044 | heterozygote | varying clinical consequence- Undef |
CF | 1987 | heterozygote | CF-causing- Undef |
CF | 1885 | heterozygote | CF-causing- Undef |
CF | 3104 | heterozygote | varying clinical consequence- Undef |
CF | 3131 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CF | 3132 | heterozygote | CF-causing - Trans |
CF | 4470 | heterozygote | CF-causing - Trans |
CF | 4058 | heterozygote | CF-causing- Undef |
CF | 4012 | heterozygote | CF-causing- Undef |
CF | 3808 | heterozygote | CF-causing - Trans |
CF | 1859 | heterozygote | CF-causing- Undef |
CF | 1812 | heterozygote | varying clinical consequence- Undef |
CF | 1805 | heterozygote | varying clinical consequence- Undef |
CF | 747 | heterozygote | CF-causing - Trans |
CF | 680 | heterozygote | likely CF - Trans |
CF | 379 | heterozygote | CF-causing - Trans |
CF | 355 | heterozygote | CF-causing - Trans |
CF | 298 | heterozygote | CF-causing - Trans |
CF | 210 | heterozygote | CF-causing- Undef |
CF | 196 | heterozygote | CF-causing- Undef |
CF | 4962 | heterozygote | CFTR-RD-causing - Trans |
CF | 4786 | heterozygote | CF-causing- Undef |
CF | 1764 | heterozygote | varying clinical consequence- Undef |
CF | 1535 | heterozygote | CF-causing - Trans CFTR-RD-causing - Trans |
CF | 1254 | heterozygote | CF-causing- Undef |
CF | 1236 | heterozygote | CF-causing - Trans |
CF | 213 | homozygote | c.2051_2052delinsG - p.(Lys684Serfs*38) - Trans |
CF | 4115 | homozygote | c.2051_2052delinsG - p.(Lys684Serfs*38) - Trans |
CF | 1937 | homozygote | c.2051_2052delinsG - p.(Lys684Serfs*38) - Trans |
CF | 4042 | homozygote | c.2051_2052delinsG - p.(Lys684Serfs*38) - Trans |
CBAVD | 3734 | heterozygote | CF-causing- Undef |
CBAVD | 433 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 429 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 395 | heterozygote | CFTR-RD-causing - Trans CFTR-RD-causing - Trans |
CBAVD | 1392 | heterozygote | VUS3- Undef |
CBAVD | 1364 | heterozygote | CFTR-RD-causing - Trans |
Bronchiectasis | 4857 | heterozygote | CF-causing - Trans |
Bronchiectasis | 1118 | heterozygote | CF-causing - Trans |
Pending | 1155 | heterozygote | VUS3 - Trans |
Pending (NBS) | 4113 | heterozygote | CFTR-RD-causing- Undef |
Pending (NBS) | 4655 | heterozygote | |
Asymptomatic compound heterozygote | 3794 | heterozygote | CFTR-RD-causing - Trans CFTR-RD-causing - Trans CFTR-RD-causing - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|